Effects a Honey Based Syrup on Blood Parameters in Patients With Breast Cancer

Phase 2

Completed

• Conditions: Breast Cancer
• Interventions: Drug: honey based (HB) syrup

• Registration Number: NCT04426435
• Lead Sponsor: Shiraz University of Medical Sciences

Brief Summary

Study aim Determination of the effect of a honey based (HB) syrup on the blood parameters of patients with breast cancer Design Two arm parallel group randomised clinical trial, double blinded Settings and conduct Design of the study: Women patients with breast cancer referring to Shohaday-e- Tajrish Hospital of Tehran who are under chemotherapy treatment. In order to blind the investigator, medications are named as "A" for syrup of HB and B for placebo. The patients don't aware of the type of drug they are assigned to. In addition, the groups are entered into statistical analysis as "A" and "B.

The patients will revive either A or B syrup for 4 weeks. At the beginning of the trial demographic data would be gathered. Also, a blood sample would be drawn at the beginning time and after the end of intervention period (week 4).

Data would be analysed by SPSS software using T-test.

Detailed Description

Women patients with breast cancer referring to Shohaday-e- Tajrish Hospital of Tehran who are under chemotherapy treatment. In order to blind the investigator, medications are named as "A" for syrup of HB and B for placebo. The patients don't aware of the type of drug they are assigned to. In addition, the groups are entered into statistical analysis as "A" and "B.

The patients will revive either A or B syrup for 4 weeks. At the beginning of the trial demographic data would be gathered. Also, a blood sample would be drawn at the beginning time and after the end of intervention period (week 4).

Data would be analysed by SPSS software using T-test. Main outcome variables The mean of score of "Hemoglobine (Hb)", 2. The mean of score of "white blood cell count (WBC)", 3. The mean of score of "platelet count (Plt)"

Main outcome variables The mean of score of "Hemoglobine (Hb)", 2. The mean of score of "white blood cell count (WBC)", 3. The mean of score of "platelet count (Plt)"

Participants/Inclusion and exclusion criteria Inclusion criteria: women suffer from breast cancer who are; 1.Age between 18- 70 years old; 2. Hemoglobin level is at least 8g/dl; 3. Hematocrit level at least 30%; 4. normal TSH. Exclusion criteria: 1. Heart disease with unstable conditions; 2. Disabling Pulmonary Disease and History of Asthma; 3. Severe kidney disease; 4. Creatinine level greater than 2mg/dl; 5. Proteinuria; 6. The SGOT level more than 3 times of the normal threshold; 7. Bilirubin levels greater than 2mg/dl; 8. Positive history of hypersensitivity to saffron, rose water and honey; 9. severe infection; 10. Systemic disease;11. Positive history of gout or high level of uric acid; 12. An individual who uses antidepressants due to depression; 13. Simultaneous use of drugs that affect fatigue; 14. Uncontrolled pain; 15. Unwillingness to participate in the study.

Study Timeline

• Study First Submitted: 2020-06-07
• Study First Submitted QC: 2020-06-07
• Study First Posted: 2020-06-11
• Study Start: 2020-06-15
• Primary Completion: 2020-09-25
• Status Verified: 2020-10
• Study Completion: 2020-10-05
• Last Update Submitted: 2020-10-06
• Last Update Posted: 2020-10-08

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Female
• Target Recruitment: 60

Inclusion Criteria

• Female gender
• Age between 18- 70 years old Patients
• known case of breast cancer
• Hemoglobin level is at least 8 g / dl
• Hematocrit level at least 30% The level of
• TSH is normal

Read More

Exclusion Criteria

• Patients known case of heart disease with unstable conditions
• Disabling Pulmonary Disease and History of Asthma
• Patients known case of severe kidney disease (Creatinine level is greater than 2mg / dl Proteinuria)
• The SGOT level is more than 3 times of the normal threshold
• Bilirubin levels is greater than 2mg / dl
• Positive history of hypersensitivity to saffron, Rose water and Honey
• Uncontrolled pain
• severe infection
• serious illness
• Positive history of gout or high level of uric acid
• An individual who uses antidepressants due to depression
• Simultaneous use of drugs that affect blood cells
• Unwillingness to participate in the study
• Active treatment for anemia (transfusion or Epoetin Alfa Injection)

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Intervention	honey based (HB) syrup	Group A: patients receiving HB syrup, 10 cc three times daily
Placebo	honey based (HB) syrup	Group B: patients receiving placebo, 10 cc three times daily

Primary Outcome Measures

Name	Time	Method
The change of mean score of Hemoglobin level of patients in intervention and placebo groups	The weeks of 0 and 4 after treatment	A mean score of hemoglobin level is generally defined as 12.5 to 14.5 grams per deciliter (125-145 grams per liter) for women. Higher or lower scores mean a worse outcome.
The change of mean score of WBC count of patients in intervention and placebo groups	The weeks of 0 and 4 after treatment	A mean score of WBC count is usually between 4,000 and 11,000 per microliter of blood for women. Higher or lower scores mean a worse outcome.
The change of mean score of Plt count of patients in intervention and placebo groups	The weeks of 0 and 4 after treatment	A mean score of Plt count is usually ranges from 150,000 to 450,000 platelets per microliter of blood for women. Higher or lower scores mean a worse outcome.

Trial Locations

Locations (1)

Shohaday-e- Tajrish Hospital; 🇮🇷 Tehran, Iran, Islamic Republic of